FDA Enforcement Class II Terminated

Supracondylar Nail T2 SCN 09x300 mm T2 Supracondylar Nail System is intended to provide strong and stable internal fixation with minimal soft tissue irritation of the distal femur. (1( Open and closed femoral fractures, (2) Pseudoarthrosis and correction osteotomy, (3) Pathologic fractures, impending pathologic fractures, and tumor resections, (4) Supracondylar fractures, including those with intra-articular extension, (5) Fractures distal to a Total Hip Prosthesis and (6) Non-unions and malunions

Recall: Z-2791-2016 · Reported September 21, 2016

Enforcement

Recall Number
Z-2791-2016
Event ID
74727
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Stryker Howmedica Osteonics Corp.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
September 21, 2016
Initiation Date
June 30, 2016
Classification Date
September 13, 2016
Termination Date
June 21, 2017
Address
325 Corporate Dr, N/A, Mahwah, NJ, 07430-2006, United States

Description

Supracondylar Nail T2 SCN 09x300 mm T2 Supracondylar Nail System is intended to provide strong and stable internal fixation with minimal soft tissue irritation of the distal femur. (1( Open and closed femoral fractures, (2) Pseudoarthrosis and correction osteotomy, (3) Pathologic fractures, impending pathologic fractures, and tumor resections, (4) Supracondylar fractures, including those with intra-articular extension, (5) Fractures distal to a Total Hip Prosthesis and (6) Non-unions and malunions

Reason

Stryker discovered that a Tibial Nail and femoral Nail were incorrectly labeled and distributed to the field.

Code Info

Catalog number 18220930S and Lot Code K836729

Distribution

US distribution to state of: CA.

Quantity

1 unit in total